| Literature DB >> 28472114 |
Manuel Revilla1,2, Anna Puig-Oliveras1,2, Anna Castelló1,2, Daniel Crespo-Piazuelo1,2, Ediane Paludo3, Ana I Fernández4, Maria Ballester5, Josep M Folch1,2.
Abstract
Copy number variations (CNVs) are important genetic variants complementary to SNPs, and can be considered as biomarkers for some economically important traits in domestic animals. In the present study, a genomic analysis of porcine CNVs based on next-generation sequencing data was carried out to identify CNVs segregating in an Iberian x Landrace backcross population and study their association with fatty acid composition and growth-related traits. A total of 1,279 CNVs, including duplications and deletions, were detected, ranging from 106 to 235 CNVs across samples, with an average of 183 CNVs per sample. Moreover, we detected 540 CNV regions (CNVRs) containing 245 genes. Functional annotation suggested that these genes possess a great variety of molecular functions and may play a role in production traits in commercial breeds. Some of the identified CNVRs contained relevant functional genes (e.g., CLCA4, CYP4X1, GPAT2, MOGAT2, PLA2G2A and PRKG1, among others). The variation in copy number of four of them (CLCA4, GPAT2, MOGAT2 and PRKG1) was validated in 150 BC1_LD (25% Iberian and 75% Landrace) animals by qPCR. Additionally, their contribution regarding backfat and intramuscular fatty acid composition and growth-related traits was analyzed. Statistically significant associations were obtained for CNVR112 (GPAT2) for the C18:2(n-6)/C18:3(n-3) ratio in backfat and carcass length, among others. Notably, GPATs are enzymes that catalyze the first step in the biosynthesis of both triglycerides and glycerophospholipids, suggesting that this CNVR may contribute to genetic variation in fatty acid composition and growth traits. These findings provide useful genomic information to facilitate the further identification of trait-related CNVRs affecting economically important traits in pigs.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28472114 PMCID: PMC5417718 DOI: 10.1371/journal.pone.0177014
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of CNVs of the seven analyzed pigs.
| Sample | Breed | No. of | No. of duplications | No. of deletions | Window size for CNV detection (kb) | Median size and (range), |
|---|---|---|---|---|---|---|
| Ib1 | Iberian | 235 | 117 | 118 | 3.39 | 3.39 (3.39–1,008.02) |
| Ib2 | Iberian | 189 | 101 | 88 | 3.34 | 3.34 (3.34–2,237.31) |
| Ld1 | Landrace | 106 | 76 | 30 | 3.39 | 6.78 (3.39–416.85) |
| Ld2 | Landrace | 203 | 117 | 86 | 3.42 | 3.42 (3.42–855.75) |
| Ld3 | Landrace | 172 | 104 | 68 | 3.22 | 3.22 (3.22–366.62) |
| Ld4 | Landrace | 208 | 122 | 86 | 3.64 | 3.64 (3.64–563.58) |
| Ld5 | Landrace | 166 | 101 | 65 | 3.24 | 3.24 (3.24–447.67) |
Fig 1Distribution of CNVRs on the different chromosomes of the porcine genome.
Each CNVR is represented by a circle and colors correspond to the different sizes explained in the legend.
Selected CNVRs for validation and association studies.
| CNVR ID | Chr | CNVR Start | CNVR End | Length (bp) | CNVR gene | Gene Start | Gene End | Gene region | Function | Overlapping with previous reports | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNVs | GWAS | DE studies | ||||||||||
| 112 | 3 | 48,486,060 | 48,496,968 | 10,908 | 48,487,404 | 48,497,055 | All gene | Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipid biosynthesis | ||||
| 157 | 4 | 141,944,876 | 142,127,882 | 183,006 | 142,080,450 | 142,110,266 | All gene | Mediates calcium-activated chloride conductance | [ | [ | ||
| 198 | 6 | 72,514,368 | 72,520,800 | 6,432 | 72,517,360 | 72,520,303 | All gene | Catalyzes the hydrolysis of the sn-2 fatty acid acyl ester bond of phosphoglycerides, releasing free fatty acids and lysophospholipids | ||||
| 214 | 6 | 151,988,436 | 151,995,708 | 7,272 | C | 151,954,326 | 152,007,678 | I6-7/E7/I7-8/E8/I8-9 | Catalyzes many reactions involved in synthesis of cholesterol, steroids and other lipids | [ | ||
| 298 | 9 | 11,128,173 | 11,133,432 | 5,259 | 11,119,062 | 11,132,962 | I2-3/E3/I3-4/E4/I4-5/E5/I5-6/E6 | Absorption of dietary fat in the small intestine | [ | |||
| 447 | 14 | 106,486,107 | 106,491,408 | 5,301 | 106,253,479 | 106,707,670 | I2-3 | Serine/threonine protein kinase that acts as key mediator of the nitric oxide (NO)/cGMP signaling | [ | |||
aDifferentially-expressed genes analysis using RNA-Seq data in IBMAP animals.
Fig 2Validation of CNVRs detected from the WGS data using qPCR analysis.
The y-axis represents the animals and the x-axis shows the relative quantification value (2-ΔΔCt values for qPCR; 2*(2^Sample signal) values for qPCR).
Fig 3Plots of analyzed CNVRs generated from CNV signal-intensity data.
The y-axis represents the CNV quantitative measurement (Peak Intensities) and the x-axis shows the different individuals. Each copy number estimation is shown in different colors. The density plot shows the distribution of these CNVs.
Statistically significant associations (q-value ≤ 0.05) between CNVR112 (GPAT2) and different phenotypic records in BC1_LD animals and their respective descriptive statistics.
| Trait | N | Mean (SEM | p-value | q-value | Coefficient of determination | ||
|---|---|---|---|---|---|---|---|
| 147 | |||||||
| C18:1(n-7) | 0.13 (0.01) | 0.14 (0.01) | 0.14 (0.01) | 1.75E-03 | 2.12E-02 | 0.12 | |
| C18:2(n-6)/C18:3(n-3) | 19.27 (0.37) | 18.29 (0.19) | 17.06 (0.25) | 9.34E-05 | 2.26E-03 | 0.17 | |
| 142 | |||||||
| C18:1(n-9) | 39.15 (0.49) | 40.31 (0.27) | 41.90 (0.81) | 9.16E-04 | 1.01E-02 | 0.14 | |
| C18:2(n-6) | 11.06 (0.43) | 10.19 (0.23) | 9.12 (0.38) | 1.53E-02 | 2.41E-02 | 0.08 | |
| C20:2(n-6) | 0.56 (0.02) | 0.53 (0.01) | 0.44 (0.03) | 1.72E-02 | 2.41E-02 | 0.07 | |
| C20:3(n-3) | 0.22 (0.02) | 0.20 (0.02) | 0.16 (0.02) | 6.44E-03 | 2.26E-02 | 0.11 | |
| C20:3(n-6) | 0.32 (0.02) | 0.27 (0.01) | 0.19 (0.04) | 5.51E-03 | 2.26E-02 | 0.09 | |
| C20:4(n-6) | 1.88 (0.15) | 1.44 (0.06) | 1.25 (0.18) | 1.02E-02 | 2.28E-02 | 0.08 | |
| MUFA | 46.97 (0.51) | 48.18 (0.30) | 49.89 (0.72) | 9.61E-04 | 1.01E-02 | 0.13 | |
| PUFA | 14.51 (0.62) | 13.07 (0.31) | 11.56 (0.56) | 6.21E-03 | 2.26E-02 | 0.10 | |
| MUFA/PUFA | 3.51 (0.19) | 3.92 (0.10) | 4.35 (0.24) | 9.18E-03 | 2.28E-02 | 0.09 | |
| MUFA/SFA | 1.23 (0.02) | 1.25 (0.01) | 1.30 (0.05) | 1.21E-02 | 2.28E-02 | 0.08 | |
| PUFA/SFA | 0.38 (0.02) | 0.34 (0.01) | 0.30 (0.02) | 1.30E-02 | 2.28E-02 | 0.08 | |
| C18:1(n-9)/C18:0 | 2.78 (0.05) | 2.85 (0.03) | 3.05 (0.18) | 1.05E-02 | 2.28E-02 | 0.09 | |
| C20:4(n-6)/C18:2(n-6) | 0.16 (0.01) | 0.14 (0.01) | 0.14 (0.02) | 1.65E-02 | 2.41E-02 | 0.07 | |
| PI | 22.32 (1.09) | 19.49 (0.49) | 17.29 (1.14) | 3.70E-03 | 2.26E-02 | 0.11 | |
| DBI | 0.81 (0.01) | 0.78 (0.01) | 0.76 (0.02) | 1.28E-02 | 2.28E-02 | 0.08 | |
| 143 | |||||||
| CRCL | 86.4 (1.37) | 83.53 (0.60) | 81.00 (7.78) | 8.97E-05 | 1.51E-03 | 0.17 | |
aStandard error of the mean.
bThe coefficient of determination reflects the genetic variability explained by CNVR112.